Showing posts with label Bacteria. Show all posts
Showing posts with label Bacteria. Show all posts

Monday, 16 November 2026

Trachoma eliminated in Eritrea.

The World Health Organization has officially validated the elimination of Trachoma, a transmissible Bacterial disease which is the world's leading infectious cause of blindness, as a public health risk, according to a press release issued on 16 November 2026. This makes Eritrea the 11th country in the World Health Organization's Africa Region (which is sub-Saharan Africa excluding Sudan, Djibouti, and Somalia, and with Algeria and Western Sahara included), and the 34th country in the world to have eliminated the disease. The conformation is therefore a another step on the way to the World Health Organization's goal of eliminating the disease worldwide by 2030.

A woman being examined for trachomatous trichiasis. Ministry of Health of Eritrea.

Trachoma was formerly endemic to Eritrea, a country where many people live in remote rural areas where access to health care and clean water and sanitation can be limited, creating conditions that facilitate the transmission of the disease. The country began the elimination process by carrying out extensive surveys to determine which areas were effected by Trachoma, then targeting local communities with antibiotics, hygene measures, and surgery to help those already impacted by the the effects of the disease. 

Trachoma is caused by the Bacterium Chlamydia trachomatis, and spread through contact with mucus emitted from the eyes and nose during infection, and can be spread by Flies. Infections are most common among children, and the disease can spread rapidly in overcrowded environments, particularly where sanitation is poor and access to clean water is limited. The Bacterium infects the inside of the eyelid, causing a roughening which can in turn lead to damage to the surface of the eye, referred to as trachomatous trichiasis. Eventually the disease can lead to the eyelids turning inwards, blinding the patient. Infections are generally fought off fairly quickly, particularly in adults, but having been infected does not offer protection against future infections, and the damage caused by each infection is cumulative. Chlamydia trachomatis is vulnerable to the antibiotics azithromycin and tetracycline.

McCoy cell monolayer micrograph reveals a number of intracellular Chlamydia trachomatis inclusion bodies; Magnified 200 times. The intracellular inclusion body represents the replication phase of the Chlamydia spp. organisms, whereupon, the reorganised reticulate body multiplies through binary fission into 100-500 new reticulate bodies, which mature into elementary bodies. Eugene Arum/Norman Jacobs/Centers for Disease Control and Prevention/Wikimedia Commons.

Eritrea is officially the 34th country to eliminate Trachoma as a public health risk, the others being Algeria, Australia, Benin, Burundi, Cambodia, China, Egypt, El Salvador, Fiji, The Gambia, Ghana, India, Iraq, Iran, Laos, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Timor-Leste, Togo, Tunisia, Vanuatu and Vietnam. Trachoma is one of twenty Neglected Tropical Diseases identified by the World Health Organization's Road Map for Neglected Tropical Diseases 2021–2030, with 68 countries now having eliminated at least one of these diseases, 23 in the African Region.

See also...

Sunday, 6 September 2026

Trachoma eliminated in Timor-Leste.

The elimination of Trachoma, a transmissible Bacterial disease which is thew world's leading infectious cause of blindness, in Timor-Leste (East Timor) has been confirmed by the World Health Organization, according to a press release issued on 3 September 2026. This conformation also marks the elimination of Trachoma across the Southeast Asia Region, with all other countries in that region either having previously eliminated the disease or never having suffered from it. The conformation is therefore a significant step on the way to the World Health Organization's goal of eliminating the disease worldwide by 2030.

The flag of Timor-Leste. Isabel Nolasco/Wikimedia Commons.

The announcement is the result of a campaign of screening which began on Atauro Island in 2015, and which has been rolled out to every region of the country. In 2025, a total of 4949 children aged 0-5 in all 13 municipalities of Timor-Leste did not find a single case of Trachoma, leading to the conclusion that the disease had been eliminated. The country does, however, plan to continue to monitor for Trachoma, and retain the ability to treat the disease.

Trachoma is caused by the Bacterium Chlamydia trachomatis, and spread through contact with mucus emitted from the eyes and nose during infection, and can be spread by Flies. Infections are most common among children, and the disease can spread rapidly in overcrowded environments, particularly where sanitation is poor and access to clean water is limited. The Bacterium infects the inside of the eyelid, causing a roughening which can in turn lead to damage to the surface of the eye. Eventually the disease can lead to the eyelids turning inwards, blinding the patient. Infections are generally fought off fairly quickly, particularly in adults, but having been infected does not offer protection against future infections, and the damage caused by each infection is cumulative. Chlamydia trachomatis is vulnerable to the antibiotics azithromycin and tetracycline.

McCoy cell monolayer micrograph reveals a number of intracellular Chlamydia trachomatis inclusion bodies; Magnified 200 times. The intracellular inclusion body represents the replication phase of the Chlamydia spp. organisms, whereupon, the reorganised reticulate body multiplies through binary fission into 100-500 new reticulate bodies, which mature into elementary bodies. Eugene Arum/Norman Jacobs/Centers for Disease Control and Prevention/Wikimedia Commons.

Timor-Leste is the 33rd country to eliminate Trachoma as a public health risk, with the other countries being Algeria, Australia, Benin, Burundi, Cambodia, China, Egypt, El Salvador, Fiji, The Gambia, Ghana, India, Iraq, Iran, Laos, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Tunisia, Vanuatu and Vietnam. Trachoma is one of twenty Neglected Tropical Diseases identified by the World Health Organization's Road Map for Neglected Tropical Diseases 2021–2030, with 68 countries now having eliminated at least one of these diseases. 

See also...

Sunday, 17 May 2026

Algeria, Australia, and Tunisia have all eliminated Trachoma as a public health risk.

On 23 April 2026 the World Health Organization published a press release confirming that Algeria had eliminated Trachoma, a transmissible Bacterial disease which is thew world's leading infectious cause of blindness. On 29 April a second press release confirmed that Australia had eliminated the disease. On 14 May a third press release confirmed that Trachoma had also been eliminated in Tunisia. This brings the number of countries which have eliminated the once widespread tropical disease to 31. Countries where it has previously been eliminated are: Benin, Burundi, Cambodia, China, Egypt, Fiji, The Gambia, Ghana, India, Iraq, Iran, Laos, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Vanuatu and Vietnam.

Regular examination of eyes at risk can help to reduce the incidence of communicable diseases such as Trachoma. Lily Solomon/World Health Organization.

Trachoma is caused by the Bacterium Chlamydia trachomatis, and spread through contact with mucus emitted from the eyes and nose during infection, and can be spread by Flies. Infections are most common among children, and the disease can spread rapidly in overcrowded environments, particularly where sanitation is poor and access to clean water is limited. The Bacterium infects the inside of the eyelid, causing a roughening which can in turn lead to damage to the surface of the eye. Eventually the disease can lead to the eyelids turning inwards, blinding the patient. Infections are generally fought off fairly quickly, particularly in adults, but having been infected does not offer protection against future infections, and the damage caused by each infection is cumulative. Chlamydia trachomatis is vulnerable to the antibiotics azithromycin and tetracycline.

McCoy cell monolayer micrograph reveals a number of intracellular Chlamydia trachomatis inclusion bodies; Magnified 200 times. The intracellular inclusion body represents the replication phase of the Chlamydia spp. organisms, whereupon, the reorganised reticulate body multiplies through binary fission into 100-500 new reticulate bodies, which mature into elementary bodies. Eugene Arum/Norman Jacobs/Centers for Disease Control and Prevention/Wikimedia Commons.

All three countries have been waging public health campaigns against Trachoma for many decades, with recent successes in eliminating infections attributed to the adoption of the World Health Organization's 'SAFE' strategy on the disease. This relies on four pillars, Surgery, which is used to save patients sight before it is lost in advances cases, Antibiotics, which are administered en masse during outbreaks, Facial cleanliness, in which large scale public health campaigns promote personal hygeine as a way to stop the spread of the disease, and Environment, in which access to clean water and good sanitation is improved. 

Mural promoting facial cleanliness to eliminate Trachoma, at Warburton in Western Australia. Minum Barreng: Indigenous Eye Health Unit/University of Melbourne/World Health Organization.

Both Algeria and Tunisia have historically had particular problems with Trachoma in their more arid southern provinces, where access to clean water has been limited. It has been estimated that in the early and mid twentieth centuries, as much as half of the population of southern Tunisia may have been affected by the disease.

World Health Organization consultant, Mario Tarizzo, prepares to take an eye smear from a school child at Srendi on the Tunisian island of Djerba. The World Health Organization has supported long-standing efforts in Tunisia to eliminate Trachoma, a disease of the eye that can cause blindness if left untreated. Eric Schwab/World Health Organization.

In Australia Trachoma was eliminated in much of the country decades ago, but has persisted in many remote Aboriginal and Torres Strait Islander communities, where access to both clean water and healthcare facilities can be very limited, and not everyone speaks English as a first language. In recent years bringing healthcare to such communities has been driven by a network of Aboriginal Community Controlled Health Organisations, which are better able to understand the healthcare needs of indigenous Australians, and deliver solutions in a culturally appropriate way.

Trachoma is one of 21 Neglected Tropical Diseases associated with devastating health, social and economic consequences outlined in the Roadmap proposed by the World Health Organization's Executive Board at its 146th session in February 2020, and adopted by the Seventy-third World Health Assembly in November 2020. This Roadmap aims to control, eliminate, or eradicate all of these diseases by 2021, in line with the United Nation's third Sustainable Development Goal: Ensure healthy lives and promote well-being for all at all ages. The elimination of Trachoma in Algeria and Tunisia makes then the 62nd and 63rd countries to have eliminated at least one Neglected Tropical Disease since the adoption of the Roadmap.

See also...

Friday, 20 March 2026

Two dead in Meningitis outbreak in Kent, southern England.

Two people have died in an outbreak of Meningitis in the city of Canterbury, in Kent, southern England, this week, according to the UK Health Security Agency. Both of those who have died have been described as having been teenage students studying at the University of Kent. A further eighteen cases of the disease have been confirmed, sixteen of whom live in or close to Canterbury, with one patient each in London and Paris, both of whom are known to have visited Canterbury immediately before becoming unwell. A further eleven possible cases are under investigation. 

The location of the University of Kent. Google Maps.

Meningitis is a serious infection of the meninges, the membranes covering the brain and spinal cord. Several different Bacteria can cause Meningitis, however, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis (sometimes spelled Neisseria meningitis) are the most common, and are transmitted from person to person through droplets of respiratory or throat secretions from infected people.

The average incubation period for Meningococcal Meningitis is 4 days, but can range between 2 and 10 days. The most common symptoms of Meningitis are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Even with early diagnosis and adequate treatment, 5% to 10% of patients die, typically within 24 to 48 hours after the onset of symptoms. Bacterial Meningitis may result in brain damage, hearing loss or a learning disability in 10% to 20% of survivors. A less common, but even more severe (and often fatal), form of Meningococcal Disease is Meningococcal Septicaemia, which is characterised by a haemorrhagic rash and rapid circulatory collapse.

The Canterbury outbreak has been linked to the B serotype of Neisseria meningitidis, a form of Betaproteobacterium. A serotype is a distinct population within a species of Bacteria or Virus which presents different antigen proteins on the surface of its cells, and therefore requires the body to develop a different antibody response. A total of 12 serotypes of Neisseria meningitides have been identified, six of which (A, B, C, W, X and Y) can cause Meningococcal Meningitis epidemics.

Two serotypes 1a and 1b with antigens 2a and 2b on surface. Corresponding antibodys 3a and 3b with the possibility to bind to the antigens. Anna Bauer/Wikimedia Commons.

In the UK, a vaccine for Neisseria meningitidis serotypes A, C, W, & Y is typically offered to school pupils aged 14-15, while a vaccine for serotype B, which is particularly associated with outbreaks in infants, is offered to babies. However, this latter vaccination was only introduced in 2015, and therefore most people over the age of 15 in the UK are not vaccinated against this strain. The charity Meningitis Now, which campaigns on issues relating to the disease in the UK, as well as offering advise to those affected by or concerned about Meningitis, has been campaigning for a roll-out of the serotype B vaccine to older groups. 

As a response to the current outbreak, the University of Kent has arranged for a vaccination program for students to be set up on its campus, where antibiotics, which can help to fight the disease, are also available. Advice for staff and students at the university can be found here. Other people who are concerned that they may have been exposed should contact their GP (a GP, or General Practitioner, is a family doctor in the UK), or the National Health Service's NHS111 help service.

Students at the University of Kent in Canterbury queuing to get Meningitis B vaccine. PA Media.

See also...